Advertisement
Screener

Amgen Inc. (AMGN) Defined Contribution Plan, Cost

2.8 / 5 stars · 68/120 Roast Me

Amgen Inc. Defined Contribution Plan, Cost

Amgen Inc. (AMGN) reported Defined Contribution Plan, Cost of $407.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-02-13

  • Amgen Inc. defined contribution plan, cost for fiscal 2025 was $407.00M, a 8.53% increase from fiscal 2024.
  • Amgen Inc. defined contribution plan, cost for fiscal 2024 was $375.00M, a 20.58% increase from fiscal 2023.
  • Amgen Inc. defined contribution plan, cost for fiscal 2023 was $311.00M, a 27.98% increase from fiscal 2022.
  • Amgen Inc. defined contribution plan, cost for fiscal 2022 was $243.00M, a 12.90% decline from fiscal 2021.
Period endDefined Contribution Plan, Cost 12 month
2025-12-31$407.00M
10-K · filed 2026-02-13
2024-12-31$375.00M
10-K · filed 2026-02-13
2023-12-31$311.00M
10-K · filed 2026-02-13
2022-12-31$243.00M
10-K · filed 2025-02-14
2021-12-31$279.00M
10-K · filed 2024-02-14
2020-12-31$231.00M
10-K · filed 2023-02-09
2019-12-31$220.00M
10-K · filed 2022-02-16
2018-12-31$173.00M
10-K · filed 2021-02-09
2017-12-31$196.00M
10-K · filed 2020-02-12
2016-12-31$174.00M
10-K · filed 2019-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
GILEAD SCIENCES, INC. (GILD)United States$185.522B-48.37
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31